Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Rifaximin

Brand: Targaxan®
NICE TA: 337
Indication: Preventing episodes of overt hepatic encephalopathy (NICE TA337)
Disease category: Infections
Commissioning responsibility: CCG
PbR excluded: No

Background

Recommended for preventing episodes of hepatic encephalopathy in people aged 18 years or older.

Recommendation

LMMG recommendation: Amber0
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

NICE TA337 - Rifaximin for preventing episodes of overt hepatic encephalopathy

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Amber

Amber

Amber0

Amber0

Amber0

Amber0